Posts by tag
oncology
Translating Global Excellence into Local Impact: Dr Fatjona Kraja and the Challenge of Transforming Radiation Oncology in Albania
Radiation oncology is one of the most technologically sophisticated and intellectually demanding disciplines in modern medicine. Yet, for Dr Fatjona Kraja, newly appointed Faculty member of the European School of Oncology (ESO) College, the field is defined not only by…
“Hope is Constant “: From Isolation and Fear to Connection, Purpose, and Global Impact
Hope as a Guiding Mantra One of my friends, a retired oncology nurse in Scotland, where I live, has become a source of hope for my family and me, and her words have become a mantra: hope is constant. Prior…
Michael Gnant at the Crossroads of Oncology: Precision, Restraint, and the Courage to Challenge Orthodoxy
Sixteen years ago, Dr. Michael Gnant was portrayed in CancerWorld as a surgical oncologist unafraid to push boundaries in breast cancer care. Today, his perspective reflects not retreat but evolution. The boundary-pusher remains, but his focus has widened. His work…
The Day Immunotherapy Went Off-Patent
In oncology, some milestones arrive with applause. Others arrive quietly. This year, one of the most important cancer drugs of the modern era begins to lose its monopoly. Nivolumab, one of the first PD-1 inhibitors to reach patients, is set…
CancerWorld #113 (March 2026)
Scientific discovery drives oncology forward, but progress only truly begins when knowledge is turned into action. Every issue of CancerWorld explores the people, ideas, and systems shaping the future of oncology. Scientific breakthroughs remain essential, but their true value emerges…
Rethinking Immunotherapy for Pancreatic Cancer: A Universal Approach
Chimeric antigen receptor natural killer T (CAR-NKT) cell therapy, a novel form of immunotherapy, is emerging as a promising ‘off-the-shelf’ treatment for patients with pancreatic cancer. In a study published in PNAS, November 21, 2025, U.S. investigators report that CAR-NKT cells…
Cary Adams: A Career of Change, Changing Careers.
He is passionate about the mission of UICC. *** When Cary Adams tells the story of how his career began, it doesn’t start with a calling in oncology. It starts with a teenage conversation about what might matter in the…
“I Live for Two”: Isabel’s Daydreaming World Between Grief and Light
When Isabel Deprince, a formerly successful model, describes the moments she feels most like herself, she doesn’t mention spotlights or runways. She talks about being alone in her studio, sleeves rolled up, paint drying on her hands. Painting, she says,…
CancerWorld #110 (December 2025)
Where progress is redesigned with purpose and delivered back to those who need it most Every issue of CancerWorld explores the places where science meets humanity, where personal stories reshape public systems, and where progress in oncology is defined not…
Metastatic Melanoma: Five Decades of Treatment Progress
In this article, we summarise a paper by Agop Y. Bedikian, published in the OncoDaily Medical Journal, tracing how care for metastatic cutaneous melanoma moved from cytotoxic agents to precision targets and immune checkpoint blockade, and what still limits durable…